未登录 Implementation of electronic prospective surveillance models in cancer care: a scoping review Lopez, Christian J.; Teggart, Kylie; Ahmed, Mohammed; Borhani, Anita; Kong, Jeffrey; Fazelzad, Rouhi; Langelier, David M.; Campbell, Kristin L.; Reiman, Tony; Greenland, Jonathan; Jones, Jennifer M.; Neil-Sztramko, Sarah E. 分享 收藏
Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis Dimopoulos, Meletios A.; Moreau, Philippe; Augustson, Bradley; Castro, Nelson; Pika, Tomas; Delimpasi, Sosana; De la Rubia, Javier; Maiolino, Angelo; Reiman, Tony; Martinez-Lopez, Joaquin; Martin, Thomas; Mikhael, Joseph; Yong, Kwee; Risse, Marie-Laure; Asset, Gaelle; Marion, Sylvia; Hajek, Roman 分享 收藏
Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN-003/MYX.1 single arm phase II trial Venner, Christopher P.; LeBlanc, Richard; Sandhu, Irwindeep; White, Darrell; Belch, Andrew R.; Reece, Donna E.; Chen, Christine; Dolan, Sean; Lalancette, Marc; Louzada, Martha; Kew, Andrea; McCurdy, Arleigh; Monteith, Bethany; Reiman, Tony; McDonald, Gail; Sherry, Max; Gul, Engin; Chen, Bingshu E.; Hay, Annette E. 分享 收藏
分享 收藏
分享 收藏
Novel anti-myeloma potential of CAPE analogs: Downregulation of IKZF1-IRF4-MYC axis Murugesan, Alli; Lasalle-Claux, Gregoire; Hogan, Lauren; Vaillancourt, Elise; Selka, Ayyoub; Luiker, Katie; Hong, Andy; Kim, MinJi; Touaibia, Mohamed; Reiman, Tony 分享 收藏
Immunohistochemical validation study of 15-gene biomarker panel predictive of benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of JBR.10 Grieve, Stacy; Ding, Keyue; Moore, Jonathan; Finniss, Mathew; Ray, Ayush; Lees, Miranda; Hossain, Faisal; Murugesan, Alli; Agar, Jane; Acar, Cenk; Taylor, James; Shepherd, Frances A.; Reiman, Tony 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group Laubach, J.; Garderet, L.; Mahindra, A.; Gahrton, G.; Caers, J.; Sezer, O.; Voorhees, P.; Leleu, X.; Johnsen, H. E.; Streetly, M.; Jurczyszyn, A.; Ludwig, H.; Mellqvist, U-H; Chng, W-J; Pilarski, L.; Einsele, H.; Hou, J.; Turesson, I.; Zamagni, E.; Chim, C. S.; Mazumder, A.; Westin, J.; Lu, J.; Reiman, T.; Kristinsson, S.; Joshua, D.; Roussel, M.; O'Gorman, P.; Terpos, E.; McCarthy, P.; Dimopoulos, M.; Moreau, P.; Orlowski, R. Z.; Miguel, J. S.; Anderson, K. C.; Palumbo, A.; Kumar, S.; Rajkumar, V.; Durie, B.; Richardson, P. G. 分享 收藏
Final Report of a Phase 2 Clinical Trial of Lenalidomide Monotherapy for Patients With T-Cell Lymphoma Toumishey, Ethan; Prasad, Angeli; Dueck, Greg; Chua, Neil; Finch, Daygen; Johnston, James; van der Jagt, Richard; Stewart, Doug; White, Darrell; Belch, Andrew; Reiman, Tony 分享 收藏
分享 收藏
分享 收藏
Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials Reiman, T.; Lai, R.; Veillard, A. S.; Paris, E.; Soria, J. C.; Rosell, R.; Taron, M.; Graziano, S.; Kratzke, R.; Seymour, L.; Shepherd, F. A.; Pignon, J. P.; Seve, P. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Interim Report of A Phase 2 Clinical Trial of Lenalidomide for T-Cell Non-Hodgkin Lymphoma Dueck, Greg; Chua, Neil; Prasad, Angeli; Finch, Daygen; Stewart, Doug; White, Darrell; van der Jagt, Richard; Johnston, James; Belch, Andrew; Reiman, Tony 分享 收藏